Coronavirus: Commission lists key steps for effective vaccination strategies and vaccines deployment

(Adam Nieścioruk, Unsplash)

This article is brought to you in association with the European Commission.


As Europe learns to live with the pandemic, the development and swift global deployment of safe and effective vaccines against COVID-19 remains an essential element in the eventual solution to the public health crisis. In this context, the Commission is working to ensure that there will be access to safe vaccines across Europe, and encourages a coordinated approach of vaccination strategies for deployment of the vaccines. Today, ahead of the discussion of EU Leaders, the Commission is presenting the key elements to be taken into consideration by Member States for their COVID-19 vaccination strategies in order to prepare the European Union and its citizens for when a safe and effective vaccine is available, as well as priority groups to consider for vaccination first.

President of the European Commission, Ursula von der Leyen, said: “A safe and effective vaccine is our best shot at beating coronavirus and returning to our normal lives. We have been working hard to make agreements with pharmaceutical companies and secure future doses. Now, we must ensure that once a vaccine is found, we are fully prepared to deploy it. With our Vaccination Strategy, we are helping EU countries prepare their vaccination campaigns: who should be vaccinated first, how to have a fair distribution and how to protect the most vulnerable. If we want our vaccination to be successful, we need to prepare now.”  

Vice-President for Promoting the European Way of Life, Margaritis Schinas, said: “While the evolution of the pandemic is getting back to March levels, our state of preparedness is not. Today we are adopting a milestone in the ongoing EU response to the COVID-19 pandemic; the aim is to ensure safe, affordable and accessible COVID-19 vaccines for all in the EU, once they will become available. It is only by acting together that we will avoid the cacophony and be more efficient than in the past.”

Stella Kyriakides, Commissioner for Health and Food Safety, said: It is with great concern that I am witnessing the increasingly rapid rise of infection rates all across the EU. Time is running out – everyone’s first priority should be to do what it takes to avoid the devastating consequences of generalised lockdowns. And we must all prepare for the next steps. The vaccine will not be a silver bullet, but it will play a central role to save lives and contain the pandemic. And when and if a safe and efficient vaccine is found, we need to be prepared to roll it out as quickly as possible, including building citizens’ trust in its safety and efficacy. Vaccines will not save lives – vaccinations will.”

In line with the 17 June EU Vaccines Strategy, the European Commission and Member States are securing the production of vaccines against COVID-19 through Advance Purchase Agreements with vaccine producers in Europe. Any vaccine will need to be authorised by the European Medicine Agency according to regular safety and efficacy standards. Member States should now start preparing a common vaccination strategy for vaccine deployment.

Member States should, among others, ensure:

  • capacity of vaccination services to deliver COVID-19 vaccines, including skilled workforce and medical and protective equipment;
  • easy and affordable access to vaccines for target populations;
  • deployment of vaccines with different characteristics and storage and transport needs, in particular in terms of cold chain, cooled transport and storage capacity;
  • clear communication on the benefits, risks and importance of COVID-19 vaccines to build public trust.

All Member States will have access to COVID-19 vaccines at the same time on the basis of population size. The overall number of vaccine doses will be limited during the initial stages of deployment and before production can be ramped up. The Communication therefore provides examples of unranked priority groups to be considered by countries once COVID-19 vaccines become available, including:  

  • healthcare and long-term care facility workers;
  • persons over 60 years of age;
  • persons whose state of health makes them particularly at risk;
  • essential workers;
  • persons who cannot socially distance;
  • more disadvantaged socio-economic groups.

Whilst awaiting the arrival of approved vaccines against COVID-19, and in parallel to safeguarding the continuation of other essential healthcare and public health services and programmes, the EU must continue mitigating the transmission of the virus. This can be done through the protection of vulnerable groups and ensuring that citizens adhere to public health measures. Until then and most likely also throughout the initial vaccination rollout phases, non-pharmaceutical interventions, such as physical distancing, closure of public places and adapting the work environment, [1] will continue to serve as the main public health tools to control and manage COVID-19 outbreaks.

Background

As Europe moves to the next stage of the COVID-19 pandemic, it is even more imperative that countries follow common vaccination strategies and approaches. At the Special European Council meeting of 2 October, Member States called on the Council and Commission to further step up the overall coordination effort and the work on the development and distribution of vaccines at EU level[2]

On 24 September, the European Centre for Disease Prevention and Control (ECDC) published its updated risk assessment regarding the COVID-19 pandemic, alongside a set of guidelines for non-pharmaceutical interventions (such as hand hygiene, physical distancing, cleaning and ventilation).

As stressed by President von der Leyen in the State of the Union 2020 Address, Europe needs to continue to handle the COVID-19 pandemic with extreme care, responsibility and unity, and use the lessons learnt to strengthen the EU’s crisis preparedness and management of cross-border health threats.

On 15 July, the Commission adopted a Communication on short-term EU health preparedness, calling on Member States to have prevention, preparedness and response measures ready in case of future COVID-19 outbreaks. The Communication made a set of recommendations to achieve this, in the areas of e.g. testing, contact tracing and health system capacities. The effective implementation of these measures requires coordination and effective information exchange between Member States. The recommendations provided in the Strategy are still relevant and Member States are encouraged to follow them.

One of the main action points necessary for Europe to overcome the coronavirus pandemic is accelerating the development, manufacturing, and deployment of vaccines against COVID-19. The EU’s vaccines strategy published in June charts the way forward.

Vaccine safety, quality and efficacy are the cornerstones of any vaccine development and authorisation process, and vaccine developers are required to submit extensive documentation and data to the European Medicines Agency through the EU Marketing Authorisation procedure. After authorisation, EU law requires that the safety of the vaccine as well as its effectiveness be monitored. Further evidence will need to be centrally collected to assess the impact and effectiveness of COVID-19 vaccines once rolled out in the population from a public health perspective. This will be key to overcoming the pandemic and instilling confidence in Europeans.

For more information

Communication on preparedness for COVID-19 vaccination strategies and vaccine deployment

Coronavirus: towards a common vaccination strategy

EU Coronavirus response factsheet

Communication on short-term EU health preparedness for future COVID-19 outbreaks

Coronavirus Vaccines Strategy

EU Coronavirus Response

Timeline of EU Action

ECDC Risk Assessment and preparedness for increased COVID-19 transmission

Recommendations for a common EU testing approach for COVID-19

[1] These include use of masks, stay-at-home orders and recommendations, closure of public places, limitations of the number of people allowed at indoor and outdoor gatherings, teleworking and adaptation of workplaces.

the sting Milestones

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

How COVID-19 is throttling vital migration flows

UN rights chief Bachelet appeals for dialogue in Sudan amid reports ‘70 killed’ in demonstrations

Asian and Pacific economies: decreases in tax revenue highlight need to broaden tax bases

Coronavirus: harmonised standards for medical devices to respond to urgent needs

Turkey: Extension of EU humanitarian programmes supporting 1.7 million refugees receives green light

Health services for Syrian women caught up in war, foster safety and hope: UNFPA

ILO: Progress on gender equality at work remains inadequate

EU plans to exploit the Mediterranean Sea and the wealth beneath it

An entrepreneurial point-of view on tackling the migration crisis and the risks of abolishing Schengen

So, what is your favourite Sustainable Development Goal?

Three ways to improve your corporate culture in the #MeToo era

Social inclusion: how much should young people hope from the EU? 

Athens urged to fast track asylum seekers amid island shelters crisis – UNHCR

Vaccination: understanding the challenges surrounding COVID-19 vaccination campaigns

What India’s route to universal health coverage can teach the world

To what extent are our moral standards responsible for killing people?

5 amazing schools that will make you wish you were young again

How to describe chronic pain beyond numbers? A Brazilian measuring instrument

Security Council must ‘come together’ to address the plight of children trapped in armed conflict, says UN envoy

Mental health as a tool of survival at the Pandemic

European Youth calls on European Council for urgent action on “humanitarian crisis” and questions the EU/Turkey deal respect of human rights

Future EU financing and recovery: MEPs to assess summit outcome

When will Eurozone’s unemployment rate stop being Europe’s worst nightmare?

Mobile World Congress 2015 first to debate EU’s new stance on Net Neutrality and Roaming Charges

Afghanistan: UN mission welcomes new polling dates following election delays

Fairness should be at the heart of the agricultural goods trade

Vaccination: understanding the challenges surrounding COVID-19 vaccination campaigns

A Sting Exclusive: “The Digital Economy and Industry are no longer opposing terms”, Commissioner Oettinger underlines live from European Business Summit 2015

Tiny Iceland teaches the West how to treat bankers

Women’s rights and how medical students can act as aides of progressive change

The results of Finland’s basic income experiment are in. Is it working?

We can decide to live within the limits of our planet

Promoting Health in the Brazilian Amazon: one nation but many cultures

ECB money bonanza not enough to revive euro area, Germany longs to rule with stagnation

New EU rules ensure better protection for 120 million holidaymakers this summer

EU Migrant Crisis: Italian Coast Guard Headquarters and Italian Navy to give host national opening addresses at Border Security 2016 in Rome

UN chief pays tribute to Egypt’s role in avoiding ‘dramatic’ escalation in conflict across the Gaza-Israel border

ACP-EU : Agreement on climate change, migration and post-Cotonou

CO2 can be a valuable raw material, not just a climate killer. Here’s how

Scientists have created biodegradable microneedles to fight eye disease

Annual UN women activists’ summit opens with focus on services, infrastructure

How start-ups will lead India through the Fourth Industrial Revolution

EU Ombudsman investigates the European Commission

EU and UK soon to be in a post-Brexit rush over free trade agreement with Australia

Commission and EIB provide CureVac with a €75 million financing for vaccine development and expansion of manufacturing

Could entrepreneurship be the real cure against the side effects of Brexit?

Rebuilding after COVID: The challenge is digital

Medical students: catalysts to close the gender gap

How the world can ‘reset’ itself after COVID-19 – according to these experts

Threat to biodiversity risks a flood of economic ruin

One third of poorer countries face both undernutrition and obesity: WHO report

State aid: Commission approves €900 million Slovenian scheme to support uncovered fixed costs of companies affected by coronavirus outbreak

Google case: A turning point in competition rules enforcement

Australia’s bushfires have pumped out half a year’s CO2 emissions

How Eurozone consumers spend their income when they have one…

25 years after population conference, women still face challenges to ‘well-being and human rights’, says UN chief

Cheese energy could power hundreds of UK homes

5G: How a ‘legion of robots’ could help save the rhino

The European Parliament fails to really restrict the rating agencies

Sponsored content: when QUALITY meets OPEX in manufacturing

More Stings?

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s